Expression of p73 protein and clinical significance in non-small cell lung cancer
Gang Chen, Dongming Chen
Abstract
Gang Chen, Dongming Chen
Abstract
Objective: To examine the expression of p73 protein in non-small cell lung cancer (NSCLC),and evaluate its clinical significance. Methods: We examined the expression of p73 protein in 85 cases of NSCLC and 32 cases of normal lung tissue with technique of immunohistochemistry. Results: Fifty-six (65.9%) cases of lung cancer and 4((12.5%)) cases of normal lung tissue had positive expression of p73 protein.The difference was significant (P0.01). Twenty-three(54.8%)cases of squamous cell cancer and 33 (76.7%) of adenocarcinoma had positive expression of p73 protein. The difference was evident (P0.05). Positive rates of p73 in cases of Ⅰ,Ⅱ,ⅢA stages were 53.3% (16/30),58.8% (10/17) ,78.9% (30/38).The expression of p73 increased with increasing of TNM (P0.05).Positive rates of p73 in N 1 to N 2 was 74.1% (40/54),and 51.6% (16/31) in N 0. The difference was significant (P0.05). Conclusion: The p73 probably plays an important role during the occurrence,development,and metastasis in lung cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To examine the expression of p73 protein in non-small cell lung cancer (NSCLC),and evaluate its clinical significance. Methods: We examined the expression of p73 protein in 85 cases of NSCLC and 32 cases of normal lung tissue with technique of immunohistochemistry. Results: Fifty-six (65.9%) cases of lung cancer and 4((12.5%)) cases of normal lung tissue had positive expression of p73 protein.The difference was significant (P0.01). Twenty-three(54.8%)cases of squamous cell cancer and 33 (76.7%) of adenocarcinoma had positive expression of p73 protein. The difference was evident (P0.05). Positive rates of p73 in cases of Ⅰ,Ⅱ,ⅢA stages were 53.3% (16/30),58.8% (10/17) ,78.9% (30/38).The expression of p73 increased with increasing of TNM (P0.05).Positive rates of p73 in N 1 to N 2 was 74.1% (40/54),and 51.6% (16/31) in N 0. The difference was significant (P0.05). Conclusion: The p73 probably plays an important role during the occurrence,development,and metastasis in lung cancer.
Key concepts: Lung cancer, Immunohistochemistry, Medicine, Clinical significance, Adenocarcinoma, Significant difference, Metastasis, Lung